- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/02 - Ophthalmic agents
Patent holdings for IPC class A61P 27/02
Total number of patents in this class: 9553
10-year publication summary
|
329
|
560
|
584
|
663
|
787
|
890
|
866
|
892
|
756
|
492
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Santen Pharmaceutical Co., Ltd. | 595 |
172 |
| Allergan, Inc. | 2169 |
139 |
| The Regents of the University of California | 20720 |
102 |
| Novartis AG | 10263 |
86 |
| Senju Pharmaceutical Co., Ltd. | 225 |
85 |
| Daiichi Sankyo Company, Limited | 1893 |
71 |
| Rohto Pharmaceutical Co., Ltd. | 409 |
70 |
| Hoffmann-La Roche Inc. | 3783 |
69 |
| Regeneron Pharmaceuticals, Inc. | 4698 |
67 |
| The Johns Hopkins University | 5875 |
66 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3337 |
61 |
| F. Hoffmann-La Roche AG | 7836 |
59 |
| Sorbonne Universite | 1394 |
52 |
| Kowa Company, Ltd. | 1234 |
46 |
| Riken | 1716 |
46 |
| Genentech, Inc. | 4099 |
44 |
| Massachusetts Eye and Ear Infirmary | 397 |
43 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3299 |
43 |
| The Trustees of Columbia University in the City of New York | 3643 |
42 |
| Novaliq GmbH | 174 |
41 |
| Other owners | 8149 |